Vulnerable populations may soon have a shield against Schistosomiasis
Poor communities, particularly in developing countries in Africa, often do not have access to potable water and adequate sanitation, increasing the threatening presence of pathogens and pathogen-carrying organisms. Six species of Schistosoma, a parasitic blood worm, penetrate the skin of people exposed to freshwater infested with the larvae. As the worms mature, they travel through the circulatory system, eventually infecting and causing massive damage to many tissues and organs. VASA is pushing a promising trademarked candidate vaccine through the clinical pipeline while ensuring access in areas with limited resources. Backed by a global consortium, VASA is dedicated to the eradication of Schistosomiasis.
Fields of science
Call for proposal
See other projects for this call
Funding SchemeRIA-LS - Research and Innovation action Lump Sum
03 Ouagadougou 03